drugset / Trial / NCT01092351

Efficacy and Safety of Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infections in Adults

NCT01092351

Phase 4 Completed 37 enrolled Mepha Ltd.
NaSingle-groupOpen-labelTreatment

Summary

The study aims to investigate bacteriological efficacy of a nitrofurantoin formulation given twice daily for seven days in the treatment of adult patients with microbiologically confirmed uncomplicated urinary tract infection. Additional study objectives are to evaluate clinical efficacy as well as safety and tolerability of the nitrofurantoin formulation.

Timeline

Start
2007-01
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitrofurantoin Unknown 100 mg